- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
-0.02| Last Update: 05/22/13 - 9:36 AM EDT |
| Volume: 34,517 |
| YTD Performance: -4.58% |
| Open: $11.01 |
| Previous Close: $11.05 |
| 52 Week Range: $8.55 - $14.19 |
| Oustanding Shares: 0 |
| Market Cap: 0 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (03/13) | Qtr (06/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.05 | $0.07 | $0.28 | $0.35 |
| Number of Analysts | 3 | 3 | 4 | 1 |
| High Estimate | $0.06 | $0.08 | $0.33 | $0.35 |
| Low Estimate | $0.04 | $0.05 | $0.22 | $0.35 |
| Prior Year | $0.01 | $-0.01 | $n.a. | $0.28 |
| Growth Rate (Year over Year) | 433.33% | 766.67% | n.a.% | 25.00% |
Accretive Health numbers lowered at OppenheimerShares of AH now seen reaching $15, Oppenheimer said. Estimates also lowered on 3Q results. Outperform rating.
Accretive Health numbers cut at Credit SuisseShares of AH now seen reaching $11, according to Credit Suisse. Estimates also reduced, given higher legal costs. Outperform rating.